C209 Pill - blue capsule/oblong, 19mm
Pill with imprint C209 is Blue, Capsule/Oblong and has been identified as Emtricitabine and Tenofovir Disoproxil Fumarate 200 mg / 300 mg. It is supplied by Cipla USA, Inc.
Emtricitabine/tenofovir disoproxil is used in the treatment of Pre-Exposure Prophylaxis of HIV; HIV Infection; Nonoccupational Exposure; Occupational Exposure and belongs to the drug class antiviral combinations. There is no proven risk in humans during pregnancy. Emtricitabine/tenofovir disoproxil 200 mg / 300 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for C209
Emtricitabine and Tenofovir Disoproxil Fumarate
- Imprint
- C209
- Strength
- 200 mg / 300 mg
- Color
- Blue
- Size
- 19.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Antiviral combinations
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Cipla USA, Inc.
- Manufacturer
- Appco Pharma LLC
- National Drug Code (NDC)
- 69097-0209
Related images for "C209"
More about emtricitabine / tenofovir disoproxil
- Check interactions
- Compare alternatives
- Reviews (43)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: antiviral combinations
Patient resources
- Emtricitabine/Tenofovir Disoproxil drug information
- Emtricitabine and tenofovir (Advanced Reading)
- Emtricitabine and Tenofovir Disoproxil Fumarate
Other brands
Truvada, AccessPak for HIV PEP Basic
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.